文献
J-GLOBAL ID:201302202859896886
整理番号:13A0289035
原発性骨粗鬆症を有し,骨折リスクの高い被験者における新たな脊椎骨折の低減を調査するテリパラチド[ヒト副甲状腺ホルモン(PTH)1-34]週1回投与有効性研究(TOWER)の無作為化試験
Randomized Teriparatide [Human Parathyroid Hormone (PTH) 1-34] Once-Weekly Efficacy Research (TOWER) Trial for Examining the Reduction in New Vertebral Fractures in Subjects with Primary Osteoporosis and High Fracture Risk
著者 (12件):
NAKAMURA Toshitaka
(Univ. of Occupational and Environmental Health, Kitakyushu, JPN)
,
SUGIMOTO Toshitsugu
(Shimane Univ. Fac. of Medicine, Izumo, JPN)
,
NAKANO Tetsuo
(Tamana Central Hospital, Tamana, JPN)
,
KISHIMOTO Hideaki
(Sanin Rosai Hospital, Yonago, JPN)
,
ITO Masako
(Nagasaki Univ. School of Medicine, Nagasaki, JPN)
,
FUKUNAGA Masao
(Kwasaki Medical School, Kurashiki, JPN)
,
HAGINO Hiroshi
(Tottori Univ., Yonago, JPN)
,
SONE Teruki
(Kawasaki Medical School, Kurashiki, JPN)
,
YOSHIKAWA Hideki
(Osaka Univ. Graduate School of Medicine, Suita, JPN)
,
NISHIZAWA Yoshiki
(Osaka City Univ., Osaka, JPN)
,
FUJITA Takuo
(Katsuragi Hospital, Kishiwada, JPN)
,
SHIRAKI Masataka
(Res. Inst. and Practice for Involutional Diseases, Azumino, JPN)
資料名:
Journal of Clinical Endocrinology & Metabolism
(Journal of Clinical Endocrinology & Metabolism)
巻:
97
号:
9
ページ:
3097-3106
発行年:
2012年09月
JST資料番号:
B0517A
ISSN:
0021-972X
資料種別:
逐次刊行物 (A)
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)